CoChat

Dopaminergic Regulation of Extracellular γ-Aminobutyric Acid Levels in the Prefrontal Cortex of the Rat

Grobin, A. Chistina, Deutch, Ariel Y. · 1998 · The Journal of Pharmacology and Experimental Therapeutics
Cited by 50

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

Dopaminergic axons in the prefrontal cortex synapse with interneurons as well as pyramidal cells. Electrophysiological data suggest that dopamine depolarizes certain g-aminobutyric acid (GABA)-containing interneurons in the cortex. We investigated the dopaminergic regulation of extracellular GABA levels in the prefrontal cortex using in vivo microdialysis. Systemic administration of the mixed D1/D2 dopamine receptor agonist apomorphine increased extracellular GABA levels in the prefrontal cortex, but did not increase levels of glycine; the apomorphineelicited increase in GABA levels was blocked by tetrodotoxin infusion into the prefrontal cortex. Local administration of the D2 agonist quinpirole into the cortex via the dialysis probe resulted in a dose-dependent increase in extracellular GABA levels. In contrast, administration of the D1 agonist SKF 38393 did not alter GABA levels. The ability of systemic apomorphine to increase extracellular GABA levels in the prefrontal cortex was blocked by local administration of the D2-like antagonist sulpiride to the cortex, but was not attenuated significantly by local perfusion of the D1 antagonist SCH 23390. Similarly, the ability of local infusion of the D2 agonist quinpirole to enhance extracellular GABA levels was blocked by sulpiride but not by SCH 23390. These data suggest that dopamine agonists increase the release of GABA in the prefrontal cortex through a D2-like receptor. In view of posited changes in prefrontal cortical dopamine and GABA systems in schizophrenia, it is possible that changes in GABAergic function in the cortex in schizophrenia are secondary to changes in cortical dopamine function. The medial PFC of the rat receives dopaminergic afferents from the mesencephalic ventral tegmental area (Fuxe et al., 1974; Swanson, 1982). Within the PFC, the major target of DA axons is the pyramidal cell (Goldman-Rakic et al., 1989; Seguela et al., 1988; van Eden et al., 1987). More recent studies indicate that DA axons also synapse onto GABA-containing interneurons in the PFC (Sesack et al., 1995; Smiley and GoldmanRakic, 1993; Verney et al., 1990). Because a single GABA interneuron may synapse with hundreds of pyramidal cells (DeFelipe et al., 1985; Freund et al., 1983), local circuit neurons play a critical role in regulating pyramidal cell function and thus cortical output. Electrophysiological studies have revealed that monoamines, including DA, excite interneurons in the PFC and other cortical regions (Gellman and Aghajanian, 1993; Penit-Soria et al., 1987; Sheldon and Aghajanian, 1990). Intracellular and whole-cell recordings from cortical interneurons indicate that monoamines depolarize these cells (Gellman and Aghajanian, 1994; Marek and Aghajanian, 1994; Yang et al., 1997; Zheng et al., 1997). Bath application of monoamines (including DA or DA agonists) to cortical slices induces bicucullinesensitive inhibitory postsynaptic potentials in pyramidal cells in the PFC (Aghajanian, 1994; Penit-Soria et al., 1987) and pyriform cortex (Sheldon and Aghajanian, 1990), and recent in vitro data indicate that low concentrations of DA depolarize certain PFC interneurons (Yang et al., 1997; Zheng et al., 1997; Charles Yang, personal communication; Wei-Xing Shi, personal communication). Consistent with the suggestion that monoamines increase GABA release from interneurons is a recent report that norepinephrine increases extracellular GABA levels in the feline visual cortex (Shirokawa and Ogawa, 1994). There have been no corresponding studies of dopaminergic regulation of extracellular GABA

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0022-3565(24)37401-4

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

See all 50

Metadata

Authors
Grobin, A. C., & Deutch, A. Y.
Venue
The Journal of Pharmacology and Experimental Therapeutics
Publisher
Elsevier BV
Published
1998-04
Volume
285
Issue
1
Pages
350-357
ISSN
0022-3565 (ISSN-L)
OpenAlex
W4406057074
Cited by
50
References
8
FWCI
1.17
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Dopaminergic Regulation of Extracellular γ-Aminobutyric Acid Levels in the Prefrontal Cortex of the Rat. https://app.cochat.ai/papers/10.1016/s0022-3565(24)37401-4
The paper
Grobin, A. C., & Deutch, A. Y. (1998). Dopaminergic Regulation of Extracellular γ-Aminobutyric Acid Levels in the Prefrontal Cortex of the Rat. The Journal of Pharmacology and Experimental Therapeutics. https://doi.org/10.1016/s0022-3565(24)37401-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.